IFN Neurologic

IFN Neurologic is a legitimate B2B healthcare platform developed by the Institute of Functional Neuroscience in partnership with MetaCell (launched ~2022). It serves a specific niche of clinicians treating neurological disorders via neuroplasticity. However, the submission itself is of extremely low quality, containing false claims (e.g., 'most people have used my product', 'audience: everyone') and lacking verifiable data on revenue or active users. While the underlying technology and utility are real and valuable, the score is heavily penalized by the lack of credible evidence provided in the submission and the niche nature of the actual product compared to the exaggerated claims.